In correlating results obtained from a new latex-Rickettsia rickettsii test with results obtained from a reference microi.mmunofluorescence test for Rocky Mountain spotted fever, we found that for seropositive patients each microimmunofluorescence titer (up to 4,096) was usually double the median titer obtained from the latex-R. rickettsii test. The pattern of immunoserological response indicated that latex-R. rickettsii is reactive with sera containing either anti-R. rickettsii immunoglobulin M (IgM) or IgG or both. The agglutination efficiency of the new test was greater when the anti-rickettsial IgM/IgG ratio was 21. Sera from late-convalescent patients were generally minimally reactive or nonreactive in the latex-R. rickettsii test unless anti-R. rickettsii IgM was present.
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Recently, Hechemy et al. (4) reported on the first-year evaluation of a latex-Rickettsia rickettsii test. During this evaluation sera from 2,656 patients were received from nine collaborating laboratories (see Acknowledgments) in states where Rocky Mountain spotted fever (RMSF) is endemic. These sera were tested in our laboratory by the newly developed latex-R. rickettsii test (2) and by the standard microimmunofluorescence (micro-IF) test (6, 7) . Results from both tests were in qualitative agreement for 2,607 patients (98%): 382 patients were seropositive, and 2,225 patients were seronegative. Re Time course of latex reactivity. Since evidence of a recent infection is usually dependent on a 2fourfold rise in titer, we compared the antibody change for 265 pairs of sera in both tests without considering the time of onset and date of collection. The tests showed agreement in 240 pairs (90.6%). Titers changed <4-fold for 21 pairs and ¢4-fold for 219 pairs in both tests; titers changed <4-fold for 11 pairs and ¢4-fold for 14 pairs in the latex-R. rickettsii test only; and titers changed <4-fold for 14 pairs and -4-fold for 11 pairs in the micro-IF test only.
To determine latex-R. rickettsii reactivity throughout the course of RMSF, we tested a total of 277 sera from patients with known dates of onset and of collection with the latex-R. rickettsii and micro-IF tests. Equivalent titers were determined, and the geometric mean for each 3-day interval was computed (Fig. 1A) . A moving average (Fig. 1B) , based on the mean for each interval plus the means for the preceding and following intervals, was also computed to smooth out variations among time intervals (9) .
Reactivity at or above the threshold value was found at a 7-to 9-day interval for both tests. This substantiates the findings of Kleeman et al. (5) .
The moving average reached its peak at 25 to 45 days for the latex-R. rickettsii test and at 31 to 35 days for the micro-IF test. After a 55-to 57-day interval, latex-R. rickettsii titers dropped below significant levels of reactivity (data not shown).
Sera were collected from three patients up to 160 days after onset (Fig. 2) . Assays of these sera indicated that latex-R. rickettsii reactivity in late convalescence correlates mainly with the presence of anti-R. rickettsii IgM. In two patients ( Fig. 2A and B) , latex-R. rickettsii reactivity dropped as IgM levels dropped. In another patient (Fig. 2C) , IgM levels remained high, as did latex-R. rickettsii reactivity. This pattern suggests that in a patient with only anti-R. rickettsii IgG response, the reactivity of the latex-R. rickettsii test would be short-lived.
In the early stages of RMSF the latex-R. rickettsii test shows reactivity with either or both of the anti-rickettsial antibody classes, but the degree of reactivity is greater with high concentrations of anti-R. rickettsii IgM. In 
